Maravai LifeSciences Holdings, Inc. (MRVI) Operating cash flow 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$57.6MFY2025 · since FY2019: $24.1M → -$57.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$57.6M | -871.2% |
| FY2024 | $7.5M | -94.1% |
| FY2023 | $126.2M | -76.4% |
| FY2022 | $536.0M | +45.4% |
| FY2021 | $368.6M | +142.2% |
| FY2020 | $152.2M | +531.1% |
| FY2019 | $24.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice